Articles Tagged with ''FDA''

Expert: UDI Could Enhance Adverse Event Reporting

Development of unique device identification (UDI), similar to the bar codes on drugs and biologics, could vastly improve the FDA's ability to respond to adverse events and track recalls, Jeff Crowley, the FDA's senior adviser for patient safety, said. Read More

FDA Issues Public Health Advisory for ESAs

The FDA issued a public health advisory last month warning physicians that use of erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of death and serious life-threatening side effects. Read More